Valuation Abbott Laboratories Swiss Exchange

Stocks

Delayed Swiss Exchange 09:06:16 18/09/2026 pm IST			5-day change	1st Jan Change
84.50 ^CHF	+1.20%		+0.60%	-14.65%

21/09	Grail rallies as FDA staff flags no major concerns for multi-cancer test	RE
18/09	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,41,365	1,91,427	1,91,088	1,96,184	2,17,859	1,78,195	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-18.21%	-	-
Enterprise Value (EV) ¹	2,49,166	1,98,318	1,98,871	2,02,693	2,22,266	2,02,134	1,99,152	1,95,462
Change	-	-20.41%	0.28%	1.92%	9.66%	-9.06%	-1.48%	-1.85%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	29.2x	22.6x	20.2x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	3.72x	3.57x	3.38x
PEG	-	-36.9x	-2x	0x	-0.7x	-5.71x	0.8x	1.7x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.55x	3.27x	3.06x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	4.03x	3.65x	3.36x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	15.6x	13.7x	12.3x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	17.2x	15.3x	13.7x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	26.8x	22.3x	20.4x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.73%	4.48%	4.91%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.571	2.741	2.896
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.5%	2.66%	2.81%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.53	4.553	5.106
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	72.8%	60.2%	56.7%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,204	54,528	58,247
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	12,989	14,491	15,854
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,719	13,021	14,319
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,303	7,978	8,906
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	23,939	20,957	17,267
Reference price ²	140.74	109.79	110.07	113.11	125.29	102.98	102.98	102.98
Nbr of stocks (in thousands)	17,14,968	17,43,574	17,36,059	17,34,455	17,38,834	17,30,383	-	-
Announcement Date	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	29.17x	4.03x	15.56x	2.5%	18TCr
MEDTRONIC PLC	19.41x	3.54x	12.67x	3.07%	12TCr
CENCORA, INC.	17.33x	0.2x	12.68x	0.75%	6.04TCr
BECTON, DICKINSON AND COMPANY	34.82x	3.38x	11.57x	2.17%	4.92TCr
HOYA CORPORATION	27.56x	6.78x	17.54x	1.45%	4.8TCr
DEXCOM, INC.	35.74x	6.29x	19.74x	-.--%	3.36TCr
MEDLINE INC.	41.26x	1.22x	11.31x	0.23%	2.8TCr
WEST PHARMACEUTICAL SERVICES, INC.	42.19x	7.4x	26.53x	0.25%	2.55TCr
SARTORIUS STEDIM BIOTECH	51.41x	6.92x	22.23x	0.41%	2.25TCr
Average	33.21x	4.42x	16.65x	1.2%	6.25TCr
Weighted average by Cap.	28.70x	3.96x	15.27x	1.86%